Pretreatment factors predicting the development of postchemotherapy nausea and vomiting in Chinese breast cancer patients

Supportive Care in Cancer

Volumn 10, Issue 2, 2002, Pages 139-145

  Molassiotis, A ^a   Yam, B M C ^b   Yung, H ^b   Chan, F Y S ^b   Mok, T S K ^b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Chemotherapy; Nausea; Nonpharmacological factors; Vomiting

Indexed keywords

ANTIEMETIC AGENT; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; METOCLOPRAMIDE; SEROTONIN ANTAGONIST;

ADULT; ANXIETY; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CHEMOTHERAPY INDUCED EMESIS; CHINESE; DEPRESSION; FATIGUE; FEMALE; HIGH RISK POPULATION; HUMAN; LABYRINTHITIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MOTION SICKNESS; PATIENT ATTITUDE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; VOMITING;

ACUTE DISEASE; ADULT; AGE FACTORS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; FEMALE; HONG KONG; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; NAUSEA; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; VOMITING; WOMEN'S HEALTH;

EID: 0036933172     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-001-0321-4     Document Type: Article

References (35)

1. Wickham R (1997) Nausea and vomiting: are they still a problem? In: Gates RA, Fink RM (eds) Oncology nursing secrets. Hanley & Belfus, Philadelphia, pp 250-261
2. Morrow GR (1992) Behavioural factors influencing the development and expression of chemotherapy induced side effects. Br J Cancer 66 [Suppl XIX]:S54-S61
3. Fessele KS (1996) Managing the multiple causes of nausea and vomiting in the patient with cancer. Oncol Nurs Forum 23:1409-1415
4. Doherty KM (1999) Closing the gap in prophylactic antiemetic therapy: patient factors in calculating the emetogenic potential of chemotherapy. Clin J Oncol Nurs 3:113-119
5. Osoba D, Zee B, Pater J, Warr D, Latreille J, Kaizer L (1997) Determinants of postchemotherapy nausea and vomiting in patients with cancer. J Clin Oncol 15:116-123
6. Du Bois A, Meerpohl HG, Vach W, Kommoss FG, Fenzl E, Pfleiderer A (1992) Course, patterns and risk-factors for chemotherapy-induced emesis in cisplatin-pretreated patients: a study with ondansetron. Eur J Cancer 28:450-457
7. Andrykowski MA, Gregg ME (1992) The role of psychological variables in post-chemotherapy nausea: anxiety and expectation. Psychosom Med 54:48-58
8. Morrow GR, Lindke J, Black PM (1991) Predicting development of anticipatory nausea in cancer patients: prospective examination of eight clinical characteristics. J Pain Symptom Manage 6:215-223
9. Wallston KA, Pointer Smith RA, King JE, Shelton Smith A, Rye P, Burish TG (1991) Desire for control and choice of antiemetic treatment for cancer chemotherapy. West J Nurs Res 13:12-29
10. Jacobsen PB, Andrykowski MA, Redd WH, Die-Trill M, Hakes TB, Kaufman RJ, Currie VE, Holland JC (1988) Nonpharmacologic factors in the development of post treatment nausea with adjuvant chemotherapy for breast cancer. Cancer 61:379
11. Andrykowski MA, Jacobsen PB, Marks E, Gorfinkle K, Hakes TB, Kaufman RJ, Currie VE, Holland JC, Redd WH (1988) Prevalence, predictors, and course of anticipatory nausea in women receiving adjuvant chemotherapy for breast cancer. Cancer 62:2607-2613
12. Nerenz DR, Leventhal H, Easterling DV, Love RR (1986) Anxiety and drug taste as predictors of anticipatory nausea in cancer chemotherapy. J Clin Oncol 4:224-233
13. Morrow GR (1985) The effects of a susceptibility to motion sickness on the side effects of cancer chemotherapy. Cancer 55:2766-2770
14. Van Komen RW, Redd WH (1985) Personality factors associated with anticipatory nausea/vomiting in patients receiving cancer chemotherapy. Health Psychol 4:189-202
15. Andrykowski MA, Redd WH (1987) Longitudinal analysis of the development of anticipatory nausea. J Consult Clin Psychol 55:36-41
16. Cull A (1992) Behavioural factors influencing the development and expression of chemotherapy induced side effects: a discussion of a paper by Dr Gary Morrow. Br J Cancer 66 [Suppl XIX]:62-63
17. McNair DM, Lorr M, Droppleman LF (1981) Manual - Profile of Mood States. Educational and Industrial Testing Services, San Diego
18. Molassiotis A, Holroyd E, Taylor-Piliae R (1999) Psychometric evaluation of the Chinese translation of the Profile of Mood States. HK Nurs J 35(2):7-12
19. Spielberger CD (1983) Manual for the State-Trait Anxiety Inventory. Clinical Psychologists Press, Palo Alto
20. Shek DTL (1993) The Chinese version of the state-trait anxiety inventory: its relationship to different measures of psychological well-being. J Clin Psychol 49:349-358
21. Morrow GR (1984) The assessment of nausea and vomiting: past problems, current issues, and suggestions for future research. Cancer 53:2267-2278
22. Morrow GR, Hickock JT, Burish TG, Rosenthal SN (1996) Frequency and clinical implications of delayed nausea and delayed vomiting. Am J Clin Oncol 19:199-203
23. Martin M (1996) The severity and pattern of emesis following different cytotoxic agents. Oncology 53 [Suppl]:26-31
24. Carey, MP, Burish TG (1988) Etiology and treatment of the psychological side effects associated with cancer chemotherapy, a critical review and discussion. Psychol Bulletin 1988; 104(3): 307-325.
25. Lichter I (1993) Which antiemetic? J Palliat Care 9:42-50
26. Katzung BG (1992) Cholinoceptor-blocking drugs. In: Katzung BG (ed) Basic and clinical pharmacology, 5th edn. Appleton & Lange, Norwalk Conn, pp 97-108
27. Burkhalter A, Frick OL (1992) Histamine, serotonin, and the ergot alkaloids. In: Katzung BG (ed) Basic and clinical pharmacology, 5th edn. Appleton & Lange, Norwalk, Conn, pp 229-247
28. Andrykowski MA (1988) Defining anticipatory nausea and vomiting: differences among cancer chemotherapy patients who report pretreatment nausea. J Behav Med 11:59-69
29. Wang JY (1983) Psychosomatic illness in the Chinese cultural context. In: Romanucci-Ross L, Moerman DE, Tancredi LR (eds) The Anthropology of Medicine. From Culture to Methods. J.F. Bergin, Praeger
30. Simms SG, Rhodes VA, Madsen RM (1993) Comparison of prochlorperazine and lorazepam antiemetic regimens in the control of postchemotherapy symptoms. Nurs Res 42:234-239
31. Pater J, Slamet J, Zee B, Osoba D, Warr D, Rusthoven J (1994) Inconsistency of prognostic factors for postchemotherapy nausea and vomiting. Support Care Cancer 2:161-166
32. Osoba D, Zee B, Warr D, Latreille J, Kaizer L, Pater J (1997) Effect of postchemotherapy nausea and vomiting on health-related quality of life. Support Care Cancer 5:307-313
33. Burish TG, Tope DM (1992) Psychological techniques for controlling the adverse effects of cancer chemotherapy: findings from a decade of research. J Pain Symptom Manage 7:287-301
34. Gralla RJ, Rittenberg C, Peralta M, Lettw L, Cronin M (1996) Cisplatin and emesis: aspects of treatment and a new trial for delayed emesis using oral dexamethasone plus ondansetron beginning 16 hours after cisplatin. Oncology 53 [Suppl 1]:86-91
35. Gralla RJ, Osoba D, Kris MG, Kirkbride P, Hesketh PJ, Chinnery LW, Clark-Snow R, Gill DP, Groshen S, Grunberg S, Koeller JM, Morrow GR, Perez EA, Silber JH, Pfister DG (1999) Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. (American Society of Clinical Oncology) J Clin Oncol 17:2971-2994